 |
The Journal of Neuroscience, December 31, 2008, 28(53):14537-14545; doi:10.1523/JNEUROSCI.2692-08.2008
Previous Article | Next Article 
Development/Plasticity/Repair
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Daniela Puzzo,1,2
Lucia Privitera,1,2
Elena Leznik,1
Mauro Fà,1
Agnieszka Staniszewski,1
Agostino Palmeri,2 and
Ottavio Arancio1
1Department of Pathology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York 10032, and 2Department of Physiological Sciences, University of Catania, Catania 95125, Italy
Correspondence should be addressed to Dr. Ottavio Arancio, Columbia University Medical Center, Department of Pathology and Cell Biology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Irving Cancer Research Center 1130 St. Nicholas Avenue, Room 603, New York, NY 10032. Email: oa1{at}columbia.edu
Amyloid-β (Aβ) peptides are produced in high amounts during Alzheimer's disease, causing synaptic and memory dysfunction. However, they are also released in lower amounts in normal brains throughout life during synaptic activity. Here we show that low picomolar concentrations of a preparation containing both Aβ42 monomers and oligomers cause a marked increase of hippocampal long-term potentiation, whereas high nanomolar concentrations lead to the well established reduction of potentiation. Picomolar levels of Aβ42 also produce a pronounced enhancement of both reference and contextual fear memory. The mechanism of action of picomolar Aβ42 on both synaptic plasticity and memory involves 7-containing nicotinic acetylcholine receptors. These findings strongly support a model for Aβ effects in which low concentrations play a novel positive, modulatory role on neurotransmission and memory, whereas high concentrations play the well known detrimental effect culminating in dementia.
Key words: amyloid-β; synaptic plasticity; memory; hippocampus; -7 nicotinic receptors; Alzheimer's disease
Received June 12, 2008;
revised Oct. 23, 2008;
accepted Nov. 18, 2008.
Correspondence should be addressed to Dr. Ottavio Arancio, Columbia University Medical Center, Department of Pathology and Cell Biology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Irving Cancer Research Center 1130 St. Nicholas Avenue, Room 603, New York, NY 10032. Email: oa1{at}columbia.edu
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2008 28: i.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
Y. Wang, M. Zhang, C. Moon, Q. Hu, B. Wang, G. Martin, Z. Sun, and H. Wang
The APP-interacting protein FE65 is required for hippocampus-dependent learning and long-term potentiation
Learn. Mem.,
August 27, 2009;
16(9):
537 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Auffret, V. Gautheron, M. Repici, R. Kraftsik, H. T. J. Mount, J. Mariani, and C. Rovira
Age-Dependent Impairment of Spine Morphology and Synaptic Plasticity in Hippocampal CA1 Neurons of a Presenilin 1 Transgenic Mouse Model of Alzheimer's Disease
J. Neurosci.,
August 12, 2009;
29(32):
10144 - 10152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tampellini, N. Rahman, E. F. Gallo, Z. Huang, M. Dumont, E. Capetillo-Zarate, T. Ma, R. Zheng, B. Lu, D. M. Nanus, et al.
Synaptic Activity Reduces Intraneuronal A{beta}, Promotes APP Transport to Synapses, and Protects against A{beta}-Related Synaptic Alterations
J. Neurosci.,
August 5, 2009;
29(31):
9704 - 9713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Dziewczapolski, C. M. Glogowski, E. Masliah, and S. F. Heinemann
Deletion of the {alpha}7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease
J. Neurosci.,
July 8, 2009;
29(27):
8805 - 8815.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|